ALNYLAM PHARMACEUTICALS, INC. Annual Depreciation in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Alnylam Pharmaceuticals, Inc. annual Depreciation history and growth rate from 2010 to 2023.
  • Alnylam Pharmaceuticals, Inc. annual Depreciation for 2023 was $51.6M, a 32% increase from 2022.
  • Alnylam Pharmaceuticals, Inc. annual Depreciation for 2022 was $39.1M, a 6.25% increase from 2021.
  • Alnylam Pharmaceuticals, Inc. annual Depreciation for 2021 was $36.8M, a 21.9% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $51.6M +$12.5M +32% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $39.1M +$2.3M +6.25% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $36.8M +$6.6M +21.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $30.2M +$13.6M +81.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $16.6M +$3.8M +29.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-10
2018 $12.8M +$900K +7.56% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 $11.9M +$2.3M +24% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 $9.6M +$2.9M +43.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-14
2015 $6.7M +$1.7M +34% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-15
2014 $5M -$1.1M -18% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-15
2013 $6.1M +$1.5M +32.6% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-12
2012 $4.6M -$400K -8% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-13
2011 $5M +$200K +4.17% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-20
2010 $4.8M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.